URSA-QUALITY-SPD1: Statin Therapy for Patients With Diabetes (SPD1)
- 17 Dec 2024
- 1 Minute to read
- Print
- DarkLight
URSA-QUALITY-SPD1: Statin Therapy for Patients With Diabetes (SPD1)
- Updated on 17 Dec 2024
- 1 Minute to read
- Print
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback
Measure Description
Among diabetes patients aged 40 to 75 without ASCVD, the percentage who were dispensed at least one statin medication of any intensity in the last 12 months. Unadjusted Certified Measure 947be984-736b-4cba-93e9-1654df8d840c
Metadata
- Measure Type: Rate Measure
- Temporal Structure: Entity
- Component Class: Normal-Form
- Denominator Case Field: Patient ID, Output NCQA Payer Type Code
- Target Direction: Up
Denominator Description
Patients aged 40-75 with diabetes and who do not have clinical atherosclerotic cardiovascular disease (ASCVD).
Numerator Description
Qualifying denominator patients who were dispensed at least one statin medication of any intensity in the prior 12 months.
*HEDISĀ® is a registered trademark of the National Committee for Quality Assurance
Was this article helpful?